Reset
Showing 6 of 26 academic articles

A Protein‐Centric Strategy Coupled with Match‐Between‐Run Glycoproteomics Enables Discovery of Robust Site‐Specific Glycan Biomarkers for Hepatocellular Carcinoma

Lei Liu, Taiheng Ma, Qi Liu, He Zhu et al. • Advanced Science (2026)

ABSTRACT Dysregulated protein glycosylation is a hallmark of cancer, and systematic investigation of glycosylation patterns is crucial for identifying biomarkers. However, current glycoproteomic studies are constrained by the limited quanti...

DOAJ Open Access (DOAJ) DOI: 10.1002/advs.202516299

Artificial intelligence in cancer target identification and drug discovery

Yujie You, Xin Lai, Yi Feng Pan, Huiru Zheng et al. • Signal Transduction and Targeted Therapy (2022)

Artificial intelligence is an advanced method to identify novel anticancer targets and discover novel drugs from biology networks because the networks can effectively preserve and quantify the interaction between components of cell systems ...

OPENALEX cc-by DOI: https://doi.org/10.1038/s41392-022-00994-0 PMC: 9090746

Risk of Ischemic Heart Disease in Patients With Postpancreatectomy Diabetes and Pancreatic Cancer: A Population‐Based Study

Daegwang Yoo, Minsun Kang, Jaehun Jung • Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease (2023)

Background Postpancreatectomy diabetes can be caused by resection of functioning pancreatic tissue and is associated with postoperative pancreatic islet cell mass loss and subsequent endocrine dysfunction. Diabetes is a well‐known risk fact...

DOAJ Open Access (DOAJ) DOI: 10.1161/JAHA.123.031321

Prediction of homologous recombination deficiency from routine histology with attention-based multiple instance learning in nine different tumor types

Chiara Maria Lavinia Loeffler, Omar S. M. El Nahhas, Hannah Sophie Muti, Zunamys I. Carrero et al. • BMC Biology (2024)

Abstract Background Homologous recombination deficiency (HRD) is recognized as a pan-cancer predictive biomarker that potentially indicates who could benefit from treatment with PARP inhibitors (PARPi). Despite its clinical significance, HR...

DOAJ Open Access (DOAJ) DOI: 10.1186/s12915-024-02022-9